Back
Business
-
Briefly
MUMBAI: Glenmark Generics, U.S. subsidiary of Glenmark Pharma, has received the ANDA (abbreviated new drug application) approval from the United States Food and Drug Administration for Ranitidine 150 mg and 300 mg tablets and will soon commence marketing and distribution of these products in the U.S. market, says a release. © Copyright 2000 - 2009 The Hindu |